Published in Ann Intern Med on November 16, 2010
Medication adherence: a call for action. Am Heart J (2011) 1.85
Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract (2011) 1.38
Completeness of prescription information in US commercial claims databases. Pharmacoepidemiol Drug Saf (2013) 1.23
Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care (2015) 1.19
Prescription abandonment: another path to medication nonadherence. Ann Intern Med (2010) 1.10
Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis (2012) 0.93
Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction. Am Heart J (2012) 0.92
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory. Pharmacoepidemiol Drug Saf (2012) 0.89
Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI). AMIA Jt Summits Transl Sci Proc (2015) 0.79
Primary adherence to antidepressant prescriptions in primary health care: a population-based study in Sweden. Scand J Prim Health Care (2016) 0.77
An overview of antimicrobial resistance and its public health significance. Braz J Microbiol (2014) 0.77
Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence. JMIR Med Inform (2016) 0.76
Refractory primary medication nonadherence: Prevalence and predictors after pharmacist counseling at hospital discharge. J Hosp Med (2015) 0.75
The 3.3 percent rx dilemma. Biotechnol Healthc (2011) 0.75
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2011) 0.75
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2011) 0.75
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Risk factors for retained instruments and sponges after surgery. N Engl J Med (2003) 8.93
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med (2006) 7.08
Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med (2006) 6.70
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA (2005) 5.96
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Physician-citizens--public roles and professional obligations. JAMA (2004) 4.68
Analysis of errors reported by surgeons at three teaching hospitals. Surgery (2003) 4.66
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
New FDA breakthrough-drug category--implications for patients. N Engl J Med (2014) 4.30
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
The reliability of medical record review for estimating adverse event rates. Ann Intern Med (2002) 4.02
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
The rise of litigation in human subjects research. Ann Intern Med (2003) 3.77
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75
Obesity and migraine: a population study. Neurology (2005) 3.67
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
The new medical malpractice crisis. N Engl J Med (2003) 3.41
Medical malpractice. N Engl J Med (2004) 3.38
Obesity--the new frontier of public health law. N Engl J Med (2006) 3.36
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Rethinking the use of physicians as hired expert lecturers. Ann Intern Med (2014) 3.22
Direct-to-consumer marketing of high-technology screening tests. N Engl J Med (2002) 3.17
Drug-review deadlines and safety problems. N Engl J Med (2008) 3.16
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med (2009) 3.08
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA (2005) 2.95
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Internet marketing of herbal products. JAMA (2003) 2.77
Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA (2004) 2.77
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
A middle ground on public accountability. N Engl J Med (2004) 2.72
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Sending pharma better signals. Science (2005) 2.69
Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med (2006) 2.67
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65